Quantcast

Latest Dendritic cell Stories

2014-05-01 08:33:37

LOS ANGELES, May 1, 2014 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) today announced that it plans to report first quarter 2014 financial results on Thursday, May 8, 2014. ImmunoCellular will host a conference call and webcast to discuss its financial results and provide a business update at 5:00 pm ET that day. The call will be hosted by Andrew Gengos, President and CEO. http://photos.prnewswire.com/prnvar/20140109/AQ43875LOGO LIVE...

2014-04-30 09:35:16

People infected with HIV whose immune cells have low cholesterol levels experience much slower disease progression, even without medication, according to University of Pittsburgh Graduate School of Public Health research that could lead to new strategies to control infection. The Pitt Public Health researchers found that low cholesterol in certain cells, which is likely an inherited trait, affects the ability of the body to transmit the virus to other cells. The discovery, funded by the...

2014-03-28 09:26:17

A combination of genetic predisposition and environmental factors is believed to cause autoimmune (type 1) diabetes. A study published on March 27th in PLOS Pathogens gets at the mechanisms by which rotavirus infection contributes to autoimmune diabetes in a mouse model of the disease. NOD (for non-obese diabetic) mice are prone to develop diabetes, and infection with rotavirus accelerates onset of the disease. Barbara Coulson and colleagues, from The University of Melbourne, Australia,...

2014-03-18 08:32:23

SEATTLE and SOUTH SAN FRANCISCO, Cali., March 18, 2014 /PRNewswire/ -- Immune Design, a clinical-stage immunotherapy company focused on the development of novel immune-based therapies for cancer and other chronic conditions, today announced the appointment of Franklin M. Berger, CFA to the company's board of directors. http://photos.prnewswire.com/prnvar/20130926/SF87058LOGO Mr. Berger is a major player in the biotechnology industry with more than 25 years of experience in capital...

2014-03-11 16:26:43

LOS ANGELES, March 11, 2014 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd. (NYSE MKT: IMUC) ("ImmunoCellular" or the "Company") today announced that it will hold its 2014 Annual Meeting of Stockholders on Friday, June 13, 2014. Because the expected meeting date for the 2014 Annual Meeting represents a change of more than thirty days from the anniversary of the Company's 2013 annual meeting of stockholders held on September 20, 2013, the Company has set a new deadline for the...

2014-03-06 08:31:36

SEATTLE and SOUTH SAN FRANCISCO, Calif., March 6, 2014 /PRNewswire/ -- Immune Design, a clinical-stage immunotherapy company focused on the development of novel immune-based therapies for cancer and other chronic conditions, today announced the appointment of biotechnology and pharmaceutical industry veteran William ("Bill") R. Ringo to the company's board of directors. http://photos.prnewswire.com/prnvar/20130926/SF87058LOGO Mr. Ringo brings more than four decades of...

2014-03-04 08:30:53

LOS ANGELES, March 4, 2014 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) today announced that it plans to report fourth quarter and full year 2013 financial results on Thursday, March 13, 2014. ImmunoCellular will host a conference call and webcast to discuss its financial results and provide a business update at 5:00 pm ET that day. The call will be hosted by Andrew Gengos, President and CEO....

2014-03-03 08:30:19

LOS ANGELES, March 3, 2014 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) today announced that Andrew Gengos, Chief Executive Officer of ImmunoCellular, will present a corporate overview and business update at the 26(th) Annual ROTH Conference on Tuesday, March 11, 2014 at 5:00 pm PT, at the Ritz-Carlton Hotel, Laguna Niguel, CA. http://photos.prnewswire.com/prnvar/20140109/AQ43875LOGO To access the live audio webcast of the ROTH...

2014-02-25 08:30:35

LOS ANGELES, Feb. 25, 2014 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) announced that the European Medicines Agency (EMA) has granted orphan drug designation for ICT-107 for the treatment of patients with glioblastoma. Granting of orphan drug status in the EU provides sponsor companies with incentives, including a 10-year period of market exclusivity, access to a centralized review process, trial design assistance and scientific advice during...

2014-02-18 09:02:53

Discovery by North Carolina researchers described at biophysical society meeting may advance development of vaccines to fight global, mosquito-borne scourge Dengue fever, an infectious tropical disease caused by a mosquito-borne virus, afflicts millions of people each year, causing fever, headache, muscle and joint pains and a characteristic skin rash. In some people the disease progresses to a severe, often fatal, form known as dengue hemorrhagic fever. Despite its heavy toll, the...


Word of the Day
attercop
  • A spider.
  • Figuratively, a peevish, testy, ill-natured person.
'Attercop' comes from the Old English 'atorcoppe,' where 'atter' means 'poison, venom' and‎ 'cop' means 'spider.' 'Coppa' is a derivative of 'cop,' top, summit, round head, or 'copp,' cup, vessel, which refers to 'the supposed venomous properties of spiders,' says the OED. 'Copp' is still found in the word 'cobweb.'
Related